{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:14:10Z","timestamp":1773278050283,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":5504,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1093\/annonc\/mdh464","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T19:33:12Z","timestamp":1100806392000},"page":"1805-1809","source":"Crossref","is-referenced-by-count":29,"title":["Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma"],"prefix":"10.1016","volume":"15","author":[{"given":"G.","family":"Toffoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cattarossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Boiocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vaccher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh464_bb0010","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood.V98.12.3406","article-title":"Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"98","author":"Kirk","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh464_bb0015","first-page":"611","article-title":"AIDS-related non-Hodgkin's lymphoma: clinico-pathological characteristics and therapeutic strategies (review)","volume":"20","author":"Silvestris","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1093\/annonc\/mdh464_bb0020","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh464_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B","article-title":"Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma","volume":"91","author":"Vaccher","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh464_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02787345","article-title":"Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma","volume":"15","author":"Sparano","year":"1998","journal-title":"Med Oncol"},{"key":"10.1093\/annonc\/mdh464_bb0035","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJM199804303381808","article-title":"HIV-protease inhibitors","volume":"338","author":"Flexner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh464_bb0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/mol.56.2.383","article-title":"Interactions of HIV protease inhibitors with ATP-dependent drug export proteins","volume":"56","author":"Gutmann","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1093\/annonc\/mdh464_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4615-1173-1_3","article-title":"MDR and MRP gene families as cellular determinant factors for resistance to clinical anticancer agents","volume":"112","author":"Deng","year":"2002","journal-title":"Cancer Treat Res"},{"key":"10.1093\/annonc\/mdh464_bb0050","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2165\/00003088-200241140-00004","article-title":"Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection","volume":"41","author":"Fichtenbaum","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1093\/annonc\/mdh464_bb0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s002800051025","article-title":"The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma","volume":"45","author":"Fumagalli","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdh464_bb0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s002800050932","article-title":"Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma\u2013drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study","volume":"43","author":"Nannan","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdh464_bb0065","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00002030-200008180-00001","article-title":"Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy","volume":"14","author":"Tirelli","year":"2000","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mdh464_bb0070","year":"1979","journal-title":"World Health Organisation. WHO Handbook for reporting results of cancer treatment. WHO offset publication No. 48. Geneva: World Health Organisation"},{"key":"10.1093\/annonc\/mdh464_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0378-4347(00)84431-X","article-title":"High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative","volume":"274","author":"Moro","year":"1983","journal-title":"J Chromatogr"},{"key":"10.1093\/annonc\/mdh464_bb0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00042560-199811010-00001","article-title":"Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells","volume":"19","author":"Washington","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1093\/annonc\/mdh464_bb0085","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","article-title":"A family of drug transporters: the multidrug resistance-associated proteins","volume":"92","author":"Borst","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdh464_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","article-title":"Clinical pharmacokinetics of doxorubicin","volume":"15","author":"Speth","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1093\/annonc\/mdh464_bb0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00002030-199810000-00008","article-title":"The pharmacokinetics of combination therapy with nelfinavir plus nevirapine","volume":"12","author":"Merry","year":"1998","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mdh464_bb0100","doi-asserted-by":"crossref","first-page":"F117","DOI":"10.1097\/00002030-199715000-00001","article-title":"Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients","volume":"11","author":"Merry","year":"1997","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mdh464_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(91)90141-K","article-title":"Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells","volume":"66","author":"Chaudhary","year":"1991","journal-title":"Cell"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419609002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419609002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/12\/1805\/830039\/mdh464.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:06:49Z","timestamp":1582247209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419609002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0923753419609002"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh464","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}